GRAPECITY PARTNERS WITH MICROSOFT AS PART OF BioIT ALLIANCE

GrapeCity — Fri, 12 Jan 2007 20:46:00 GMT

January 12, 2007 02:12 PM Pacific Time

KIRKLAND, Wash.--(BUSINESS WIRE)--GrapeCity today announced that it is joining the Microsoft-sponsored BioIT Alliance, which is dedicated to leveraging information technology to speed the introduction of new, personalized forms of medicine. GrapeCity, a long-time Microsoft Partner, will apply its core strengths in Microsoft Office and .NET technologies to provide the Alliance with unique solutions for regulatory-compliant information authoring and management -- solutions that will enable users to work with familiar Microsoft Office products, such as Word, rather than having to learn XML or specialized authoring tools.

Commenting on GrapeCity’s participation in the Alliance, Sanjeev Jagtap, GrapeCity Director of Product Management, said, "To maintain a healthy drug pipeline, pharmaceutical companies need a robust drug discovery and development process that’s also easy to work with. GrapeCity has already developed FDA-compliant XML Structured Product Labeling solutions that are integrated with Microsoft Office, making them easy to use and to support. We are committed to replicating this success in other phases of the drug development life cycle."

“We are very pleased to have GrapeCity join the BioIT Alliance,” added Don Rule, Microsoft’s platform strategy advisor and BioIT Alliance director. “Their expertise in regulatory compliance technology will help our members more easily turn the data they generate today into pharmaceutical products for tomorrow.”

About GrapeCity

GrapeCity is an award-winning software development firm with headquarters in Japan and more than 700 employees worldwide. For over 25 years, the company has provided enterprises around the world with state-of-the-art software services and solutions. For more information, visit http://www.grapecity.com.

About the BioIT Alliance

Formed in 2006, the BioIT Alliance is a cross-industry group working to integrate science and technology in order to accelerate the pace of drug discovery and realize the potential of personalized medicine. Founding members include Accelrys Software Inc., Affymetrix, Inc., Agilent Technologies Inc., Amylin Pharmaceuticals, Inc., Applied Biosystems, The BioTeam Inc., Digipede Technologies LLC, Discovery Biosciences Corporation, Geospiza Inc., Hewlett-Packard Development Company, L.P., Illumina Inc., InterKnowlogy, Microsoft Corporation, Sun Microsystems Inc., The Scripps Research Institute, VizX Labs LLC and other key companies in the pharmaceutical, biotech, hardware and software industries. For more information, visit http://www.bioitalliance.org.

Contacts

GrapeCity USA
David Watts, Senior Director of Sales, 425-285-2341
david.watts@grapecity.com

GRAPECITY INTRODUCES EASY-TO-USE MICROSOFT WORD BASED FDA-SPL COMPLIANT AUTHORING SOLUTION

GrapeCity — Fri, 12 Jan 2007 00:39:00 GMT

GrapeCity, a long-time Microsoft Partner, has leveraged its core strengths in Microsoft Office and .NET technologies to provide the Industry with unique solutions for regulatory-compliant information authoring and management—solutions that will enable users to work with familiar Microsoft Office products, such as Word, rather than having to learn XML or specialized authoring tools.

The solution targets FDA's new labeling submissions for prescription drugs using a new XML based format called Structured Product Labeling (SPL). By the end of 2007, the requirement to submit labeling information in SPL will extend to all FDA-regulated products: OTC medications, devices, diagnostics, veterinary medicines-any product with package information or a package insert.

Learn more at http://www.grapecity.com/us/lifesciences_usa.asp